Plant Products as Inhibitors of Coronavirus 3CL Protease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

22 citing papers in PubMed, 63 citations in OpenAlex.

1. Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 MMolecules (Basel, Switzerland) · 2025
   Review
2. Ethnobotanical survey of herbal medicines for anti-COVID-19 used by traditional Chinese medicine pharmacies in Taiwan.Frontiers in pharmacology · 2025
   Article
3. Bioactive Compound Chemistry and Antiasthmatic Activity of Betulinic Acid and Taraxerol in Experimental Models.Current topics in medicinal chemistry · 2025
   Article
4. The Identification of Peptide Inhibitors of the Coronavirus 3CL Protease from aMarine drugs · 2024
   Article
5. Effectiveness of the antiviral medications azvudine and nirmatrelvir-ritonavir in treating COVID-19 in patients with hematological malignancies.Clinics (Sao Paulo, Brazil) · 2024
   Observational
6. Antiviral Effects of Pyrroloquinoline Quinone through Redox Catalysis To Prevent Coronavirus Infection.ACS omega · 2023
   Article
7. In silico guided screening of active components of3 Biotech · 2023
   Article
8. Oridonin inhibits SARS-CoV-2 replication by targeting viral proteinase and polymerase.Virologica Sinica · 2023
   Article
9. An Attention towards the Prophylactic and Therapeutic Options of Phytochemicals for SARS-CoV-2: A Molecular Insight.Molecules (Basel, Switzerland) · 2023
   Review
10. Masitinib analogues with theJournal of King Saud University. Science · 2023
    Article
11. The SARS-CoV-2 main protease (MMedComm · 2022
    Review
12. The effect of various compounds on the COVID mechanisms, from chemical to molecular aspects.Biophysical chemistry · 2022
    Review
13. The Main Protease of SARS-CoV-2 as a Target for Phytochemicals against Coronavirus.Plants (Basel, Switzerland) · 2022
    Review
14. Editorial: Plant products for antiviral therapeutics.Frontiers in pharmacology · 2022
    Article
15. Antiviral drug discovery by targeting the SARS-CoV-2 polyprotein processing by inhibition of the main protease.PeerJ · 2022
    Article
16. The current status of old traditional medicine introduced from Persia to China.Frontiers in pharmacology · 2022
    Review
17. Review on Plant-Based Management in Combating Antimicrobial Resistance - Mechanistic Perspective.Frontiers in pharmacology · 2022
    Review
18. Exploring the Targets of Novel Corona Virus and Docking-based Screening of Potential Natural Inhibitors to Combat COVID-19.Current topics in medicinal chemistry · 2022
    Article
19. Herbal medicine use for the management of COVID-19: A review article.Metabolism open · 2021
    Article
20. Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19.Environmental science and pollution research international · 2021
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors at 2 institutions in 2 countries.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as